A 63 year old man was transferred from outside facility with ventricular tachycardia. He has a past history of ventricular tachycardia and had an intracardiac defibrillator (ICD) placed due to a low ejection fraction. The ICD had administered several shocks to the patient prior to admission.
testing, possibly related to amiodarone or to kyphosis. He is a life-long nonsmoker.
Physical Examination
His vital signs included a Tmax of 38.8 C, heart rate of 79 beats/min, blood pressure of 113/67 mm Hg, respiratory rate of 38 breaths/min, and oxygen saturation of 94% on a 75% high flow mask. His weight had increased to 102 kg from 96.6 kg on admission. Cardiovascular exam revealed an irregular rhythm but no murmur. There was jugular venous distention present. There was a trace of pedal edema but deeper pitting edema at the hips. Pulmonary auscultation revealed bilateral rales with diminished breath sounds at the bases.
Chest X-ray
Admission and current chest x-ray are shown in Figure 1 . 
Laboratory Evaluation
Arterial blood gases showed a pH of 7.42, a pCO 2 of 39 and a pO 2 of 73 on 70% FiO 2 . The white blood cell count (WBC) was elevated at 15.1X10 3 cells/mm 3 .
Which of the following could explain the patient's increased oxygen requirements?
1. Pulmonary edema 2. Pneumonia 3. Amiodarone lung toxicity 4. A + B 5. A + C 6. All of the above
Correct! 6. All of the above
Pulmonary edema is possible from either a cardiac cause because of his history of heart failure and his positive fluid balance or from a noncardiac cause. Pneumonia is possible with his fever, elevated WBC and clinical situation of recent intubation. Amiodarone lung toxicity given the large amount he has received and can present with an acute syndrome which mimics pulmonary edema or pneumonia.
A CT scan was performed ( Figure 2 ). In our view bronchoscopy is the next logical choice. Switching antibiotics or adding amphotericin would not seem appropriate with the patient becoming afebrile and a decreasing WBC. Steroids for amiodarone toxicity is not wrong but this is a diagnosis of exclusion and other causes have not been totally excluded. Lung biopsy is not wrong but does seem overly aggressive since not all less invasive procedures have been performed.
Bronchoscopy showed purulence noted at the left lower lobe orifice. Bronchoalveolar lavage was performed of the right middle lobe (due to the CT findings) and washings were performed of the left lower lobe.
All the cultures were negative. Cytology revealed no malignancy, fungi or viral inclusions.
Because the diagnosis was still unclear a video-assisted thorascopic (VATS) biopsy was performed ( Figure 4 ). 
Correct! 3. Amiodarone lung toxicity
Amiodarone lung toxicity is a clinical diagnosis made with a compatible clinical situation, absence of other likely diagnosis and compatible pathology. This case would fulfill all criteria.
The incidence of amiodarone toxicity is estimated at 1-15%. Risk factors include:
 Age (3x for every 10 years >60 years)  Male gender (HR 1.37)  Underlying lung disease  Thoracic surgery  Pulmonary angiography  Dose…
The highest risk is in men over the age of 60 years on who have received amiodarone for 6-12 months. Dose associations can be either accumulative or daily dosing. With higher daily doses (>400mg) there is a 5-15% incidence but with lower doses used today (< 400 mg) the incidence is about 2%. 
Correct! 4. Lung transplantation
Removal of the offending agent is usually recommended although amiodarone has a very long elimination half-life and this alone is often ineffective. Of course, supportive care is recommended but the mainstay of therapy is corticosteroids. These are usually initiated at 0.5-1 mg/ kg and tapered gradually as tolerated over 2-6 months. Symptoms can recur during taper and returning to the last effective dose and then slowly tapering is recommended.
Therapy for our patient was initiated with high-dose corticosteroids which resulted in improved oxygenation. However, he developed subcutaneous emphysema with a persistent airleak, volume overload requiring hemofiltration, elevated liver function tests, thrombocytopenia, and functional deficits requiring rehabilitation.
He slowly improved on tapering doses of prednisone and had no recurrence of symptoms. His SpO 2 is 95% on room air and is walking 1000 feet and doing 30 deep knee bends without dyspnea. He has no recurrence of his ventricular tachycardia.
